Letrozole tablets: Clinical Trials

4 trials of Letrozole tablets, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed, 1 unknown. 4 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Recruiting 2, Completed 1, Unknown 1
Phase 12Recruiting 2
Phase 31Unknown 1

Follow Letrozole tablets: new trials by email Literature Review of Letrozole tablets trials Research Report on Letrozole tablets

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Breast Cancer
HRS-6208 Capsule, HRS-6209 Capsule, HRS-8080 Tablet - Advanced Unresectable or Metastatic Breast Cancer of Adults
Phase 1 / Phase 2RecruitingShandong Suncadia Medicine Co., Ltd.1802026-03-272026-04-03
A Clinical Study of HRS-6209 Combined With Other Treatment Regimens in Patients With Breast Cancer
HRS-6209 Capsules, Letrozole Tablets, HRS-2189 Tablets - Breast Cancer
Phase 1 / Phase 2RecruitingJiangsu HengRui Medicine Co., Ltd.802025-05-222026-06-12
Impact of Co Enzyme Q10 as Adjuvant Therapy to Letrozole on Spermiogram
Letrozole tablets, Coenzyme Q10 table - Male Reproductive Problem, Infertility, Male
Phase 2CompletedAl-Mustansiriyah University742021-12-012025-02-19
Letrozole as a Prophylaxis From GTN for Complete Mole Patients
Suction evacuation, Letrozole tablets - Gestational Trophoblastic Disease
Phase 2 / Phase 3UnknownZagazig University2002020-06-012022-07-12

Conditions studied

Breast Neoplasms (1)  ·  Gestational Trophoblastic Disease (1)  ·  Hydatidiform Mole (1)  ·  Infertility, Male (1)

Sponsors

Al-Mustansiriyah University (1)  ·  Jiangsu HengRui Medicine Co., Ltd. (1)  ·  Shandong Suncadia Medicine Co., Ltd. (1)  ·  Zagazig University (1)

Countries

China (2)  ·  Egypt (1)  ·  Iraq (1)

Top investigators

Mohamed A Alabiad, MD (1)

Results publications

PMID 38957201